Abstract
Dissecting the genetic basis of complex diseases remains one of great challenges in human genetics, because these diseases have polygenic determinations and involve multiple gene-gene and gene-environmental interactions. Definite conclusions about finding genes underlying complex diseases need substantial evidence from three levels of gene function. The traditional strategy of gene identification is to determine putative susceptibility genes on the DNA level, and then to find related association between susceptibility genes and complex diseases on the RNA and protein levels. However, with rapid development of technologies of proteomics and microarrays, a new high-throughput strategy backward from protein to RNA and further to DNA becomes available for gene discovery. This strategy can systemically test gene expression, analyze co-expressed genes or regulatory network, and detect the effects of environmental factors on the onset and development of complex diseases. Here we attempt to outline these two strategies using obesity as an example of a complex disease, and to compare their advantages and disadvantages. In conclusion, we suggest that these two strategies may complement each other and thus help to uncover a more comprehensively and more completely multifaceted spectrum of genetic determination for complex diseases.
Keywords: Complex disease, obesity, proteomics, microarray, gene identification
Current Genomics
Title: Two Strategies to Identify Genes Underlying Complex Diseases
Volume: 6 Issue: 7
Author(s): Shu-Feng Lei, Shan Wu, Volodymyr Dvornyk and Hong-Wen Deng
Affiliation:
Keywords: Complex disease, obesity, proteomics, microarray, gene identification
Abstract: Dissecting the genetic basis of complex diseases remains one of great challenges in human genetics, because these diseases have polygenic determinations and involve multiple gene-gene and gene-environmental interactions. Definite conclusions about finding genes underlying complex diseases need substantial evidence from three levels of gene function. The traditional strategy of gene identification is to determine putative susceptibility genes on the DNA level, and then to find related association between susceptibility genes and complex diseases on the RNA and protein levels. However, with rapid development of technologies of proteomics and microarrays, a new high-throughput strategy backward from protein to RNA and further to DNA becomes available for gene discovery. This strategy can systemically test gene expression, analyze co-expressed genes or regulatory network, and detect the effects of environmental factors on the onset and development of complex diseases. Here we attempt to outline these two strategies using obesity as an example of a complex disease, and to compare their advantages and disadvantages. In conclusion, we suggest that these two strategies may complement each other and thus help to uncover a more comprehensively and more completely multifaceted spectrum of genetic determination for complex diseases.
Export Options
About this article
Cite this article as:
Lei Shu-Feng, Wu Shan, Dvornyk Volodymyr and Deng Hong-Wen, Two Strategies to Identify Genes Underlying Complex Diseases, Current Genomics 2005; 6 (7) . https://dx.doi.org/10.2174/138920205775067710
DOI https://dx.doi.org/10.2174/138920205775067710 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements